Gees don't be swayed by me.
But when you can get exposure to some really good assets at a 40% discount...
Like you identified though, the fee structure is absolutely disgraceful.
I have been following one of their investments, Imugene for a very long time. In the Australian biotech scene, they are at the forefront of cancer treatment.
How long can you possibly justify keeping a fund going when it's trading at nearly half its NAV???
Thoughts, page-12
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TEK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.3¢ |
Change
-0.003(1.85%) |
Mkt cap ! $52.70M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.0¢ | $78.47K | 595.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 311202 | 4 |
View Market Depth
| Last trade - 15.45pm 26/07/2024 (20 minute delay) ? |
| TEK (ASX) Chart |